Research Topics
| Andrew S ArtzSummaryAffiliation: University of Chicago Country: USA Publications
| Collaborators
|
Detail Information
Publications
Pneumococcal vaccination and revaccination of older adultsAndrew S Artz
The Institute for Advanced Studies in Aging and Geriatric Medicine, Washington, D C, USA
Clin Microbiol Rev 16:308-18. 2003..In the meantime, administering to PPV to recommended groups should be a public health priority...- Unexplained anemia predominates despite an intensive evaluation in a racially diverse cohort of older adults from a referral anemia clinicAndrew S Artz
Section of Hematology Oncology, University of Chicago, 5841 S Maryland Avenue, Chicago, IL 60605, USA
J Gerontol A Biol Sci Med Sci 66:925-32. 2011..To accurately determine the causes of anemia and proportion of unexplained anemia in a racially diverse cohort of older adults after a comprehensive and standardized evaluation... - Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantationAndrew S Artz
Section of Hematology Oncology, Department of Medicine, University of Chicago, the University of Chicago Cancer Research Center, Chicago, Illinois 60637, USA
Biol Blood Marrow Transplant 14:1209-16. 2008..These data require confirmation in non-T cell-depleted conditioning regimens. If validated, they suggest that preconditioning CRP holds promise for enhancing estimates of transplantation tolerance... - Anemia and the frail elderlyAndrew S Artz
Section of Hematology Oncology, University of Chicago Pritzker School of Medicine, 5841 S Maryland Avenue, Chicago, IL 60637, USA
Semin Hematol 45:261-6. 2008..Anemia interventional studies are sorely needed to determine whether treatment may mitigate either the development of frailty and/or the sequela of frailty... - Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantationAndrew S Artz
Section of Hematology Oncology, University of Chicago, Chicago, Illinois 60637, USA
Biol Blood Marrow Transplant 12:954-64. 2006..001) and enhanced prognostic power over the CCI alone (P = .018). Prospective studies evaluating more comprehensive functional and comorbidity measurements are warranted... - Order of patient entry influences outcome for metastatic renal cell cancer after non-myeloablative allogeneic stem cell transplantationAndrew S Artz
Department of Medicine, Section of Hematology Oncology, School of Medicine, University of Chicago, Chicago, IL, USA
Br J Haematol 132:747-54. 2006..Further studies are warranted to determine the influence of order of patient entry in other early clinical trial settings... - Mechanisms of unexplained anemia in the nursing homeAndrew S Artz
Institute for Advanced Studies in Aging and Geriatric Medicine, Washington, DC, USA
J Am Geriatr Soc 52:423-7. 2004..To characterize anemia in elderly nursing home residents... - Long-term follow-up of nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma: The University of Chicago ExperienceA S Artz
University of Chicago Hospitals, Chicago, IL 60637 1470, USA
Bone Marrow Transplant 35:253-60. 2005..002). NST leads to durable responses in a minority of metastatic RCC patients. Appropriate patient selection is paramount. Anemia and decreased performance status may enable risk stratification... - Prevalence of anemia in skilled-nursing home residentsAndrew S Artz
Institute for Advanced Studies in Aging and Geriatric Medicine, 1700 Wisconsin Avenue, NW, 1st Floor, Washington, DC 20007, USA
Arch Gerontol Geriatr 39:201-6. 2004.... - Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrenceKoen Van Besien
Section of Hematology Oncology, University of Chicago, Chicago, IL 60637, USA
Leuk Lymphoma 50:1809-17. 2009..The high incidence of MDC after alemtuzumab containing conditioning contributes to the low risk of acute and chronic GVHD... - T-cell-depleted allogeneic transplant without donor leukocyte infusions results in excellent long-term survival in patients with multiply relapsed Lymphoma. Predictors for survival after transplant relapseVaishalee P Kenkre
Section of Hematology Oncology, Department of Medicine, University of Chicago Medical Center, Chicago, IL 60637, USA
Leuk Lymphoma 52:214-22. 2011..Our outcomes challenge the utility of the common practice of prophylactic DLI after T-depleted transplant for lymphoma... - Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissionsHongtao Liu
Section of Hematology Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA
Blood 118:6438-45. 2011..Therefore, UCB selection can prioritize matching, and better matched donors can be identified rapidly for most patients. This study is registered at http://clinicaltrials.gov as NCI clinical trial no. NCT00943800... - Phase I study of dose-escalated busulfan with fludarabine and alemtuzumab as conditioning for allogeneic hematopoietic stem cell transplant: reduced clearance at high doses and occurrence of late sinusoidal obstruction syndrome/veno-occlusive diseasePeter H O'Donnell
Department of Medicine, The University of Chicago, Chicago, IL 60637, USA
Leuk Lymphoma 51:2240-9. 2010..This AUC is now being studied in phase II for patients receiving busulfan/fludarabine/alemtuzumab as alloHCT conditioning... - BK virus infection is associated with hematuria and renal impairment in recipients of allogeneic hematopoetic stem cell transplantsPeter H O'Donnell
Section of Hematology Oncology, Department of Medicine, The University of Chicago, 5841 S Maryland Avenue, Chicago, IL, 60637, USA
Biol Blood Marrow Transplant 15:1038-1048.e1. 2009..Investigation of whether prophylaxis against, or treatment of, BKV in the post-HSCT setting mitigates the associated morbidities, especially kidney injury, warrants prospective evaluation... - Diminished quality of life and physical function in community-dwelling elderly with anemiaMya Thein
Institute for Advanced Studies in Aging and Geriatric Medicine, Washington, DC, USA
Medicine (Baltimore) 88:107-14. 2009..Mildly low hemoglobin levels, even when above the World Health Organization (WHO) anemia threshold, were associated with significant declines in quality of life among the elderly... - Gene mutations, epigenetic dysregulation, and personalized therapy in myeloid neoplasia: are we there yet?Olatoyosi Odenike
Department of Medicine, The University of Chicago, Chicago, IL 60637, USA
Semin Oncol 38:196-214. 2011.... - Serum erythropoietin and aging: a longitudinal analysisWilliam B Ershler
Institute for Advanced Studies in Aging, Washington, DC, USA
J Am Geriatr Soc 53:1360-5. 2005..To determine the changes in serum erythropoietin with age in patients with and without anemia and to assess the importance of certain comorbidities on changes in erythropoietin level and the development of anemia... - Individual physician practice variation in hematopoietic cell transplantationStephanie J Lee
Division of Clinical Research, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D5 290, Seattle, WA 98109, USA
J Clin Oncol 26:2162-70. 2008..Previous studies have evaluated practice variation in hematopoietic cell transplantation (HCT) among transplant centers and countries. There are no studies investigating individual physician practice variation in HCT... - Prevalence of anemia in the nursing home: contribution of chronic kidney diseaseBruce Robinson
Department of Geriatrics, Florida State University College of Medicine, Sarasota, Florida, USA
J Am Geriatr Soc 55:1566-70. 2007..To assess the independent contribution of chronic kidney disease (CKD) and age to anemia in older nursing home residents...